Medicine and Dentistry
Breast Cancer
94%
Malignant Neoplasm
87%
Disease
85%
Asthma
70%
Neoplasm
56%
Women's Health
50%
Physical Activity
43%
Oncology
39%
Hazard Ratio
39%
Prostate Cancer
38%
Wheeze
38%
Symptom
36%
Postmenopause
35%
Biological Marker
31%
Obstructive Sleep Apnea
30%
Nodular Melanoma
29%
Clinical Trial
28%
Overall Survival
27%
Odds Ratio
27%
Colorectal Cancer
26%
Placebo
25%
Chronic Obstructive Pulmonary Disease
24%
Heart Failure
24%
Cancer Risk
23%
Cardiovascular Disease
22%
Metastatic Carcinoma
22%
Cardiovascular System
22%
Body Mass Index
22%
COVID-19
21%
In Vitro
20%
Pediatrics
19%
Childbirth
19%
Colon Cancer
19%
Radiation Therapy
18%
Dietary Pattern
18%
Cancer Prevention
17%
Cancer Mortality
17%
Recurrent Disease
17%
Sleep Time
17%
Myocardial Infarction
16%
Integrin
16%
Infection
16%
Non Small Cell Lung Cancer
16%
Respiratory Disease
15%
Magnetic Resonance Imaging
15%
Positive Airway Pressure
15%
Prostate Carcinoma
15%
Prevalence
15%
Doxorubicin
15%
Gene Expression
15%
Small Cell Lung Cancer
14%
Quality of Life
14%
Adenoma
14%
Surgery
14%
Ovarian Cancer
14%
Sleep Disorder
14%
Randomized Controlled Trial
14%
Proportional Hazards Model
13%
Systematic Review
13%
Cyclophosphamide
13%
Diagnosis
13%
Drug Therapy
13%
Colorectal Adenoma
13%
Metastatic Breast Cancer
12%
Bone Marrow Transplantation
12%
Sleep Medicine
12%
Acute Respiratory Distress Syndrome
12%
Obesity
12%
Tumor Cell
12%
Cohort Analysis
12%
Severe Acute Respiratory Syndrome Coronavirus 2
12%
Adjuvant Therapy
12%
Heart Failure with Preserved Ejection Fraction
12%
Metastatic Melanoma
12%
Lung Transplantation
11%
Epithelial Cell
11%
Disease Free Survival
11%
Bone Metastasis
11%
Biopsy
11%
Progression Free Survival
11%
Cisplatin
11%
Transplantation
11%
Diabetes
11%
Rectum Cancer
11%
Prognostic Factor
10%
Prostate Specific Antigen
10%
Nonalcoholic Fatty Liver
10%
Acute Myeloid Leukemia
10%
Public Health
10%
Health Care Cost
9%
Colonoscopy
9%
Phase II Trials
9%
Extracellular Matrix
9%
Artificial Respiration
9%
Frailty
9%
Drug Megadose
9%
Diet Therapy
9%
Hematopoietic Stem Cell
9%
Cancer Incidence
9%
Forced Expiratory Volume
9%
Pharmacology, Toxicology and Pharmaceutical Science
Disease
100%
Asthma
87%
Neoplasm
71%
Breast Cancer
71%
Malignant Neoplasm
63%
Chemotherapy
58%
Mouse
55%
Placebo
47%
Nonalcoholic Fatty Liver
45%
Heart Failure
38%
Cyclophosphamide
37%
Melanoma
36%
Doxorubicin
36%
Prostate Cancer
35%
Clinical Trial
34%
Overall Survival
32%
Symptom
31%
Sleep Disordered Breathing
31%
Cisplatin
30%
Wheezing
29%
Biological Marker
26%
Non Small Cell Lung Cancer
24%
Pharmacokinetics
24%
Lung Cancer
23%
Phase II Trials
21%
Metastatic Breast Cancer
21%
Heart Failure with Preserved Ejection Fraction
21%
Heart Infarction
20%
Paclitaxel
20%
Colon Cancer
19%
Prostate Carcinoma
18%
Progression Free Survival
18%
Chronic Obstructive Lung Disease
18%
Colorectal Cancer
17%
Etoposide
17%
Remission
16%
Imexon
16%
Recurrent Disease
15%
Infection
15%
Prevalence
15%
Prostate Specific Antigen
15%
Cardiovascular Disease
15%
Dry Powder Inhaler
15%
Small Cell Lung Cancer
14%
Disease Free Survival
14%
Metastatic Melanoma
14%
Cohort Study
14%
Immunotherapy
14%
Acute Heart Infarction
13%
Inflammation
13%
Colorectal Adenoma
13%
Solid Malignant Neoplasm
12%
Pancreas Cancer
12%
Adult Respiratory Distress Syndrome
12%
Tumor Necrosis Factor
12%
Nanoparticle
12%
Denosumab
11%
Bone Metastasis
11%
Spironolactone
11%
Cell Culture
11%
Vitamin D
11%
Metastasis
10%
Sleep Disorder
10%
Xenobiotic Agent
10%
Survival Rate
10%
Fluorouracil
10%
Tamoxifen
10%
Myeloma
10%
Randomized Clinical Trial
9%
Bile Acid
9%
Choline
9%
Mitomycin
9%
Cytotoxicity
9%
Pulmonary Hypertension
9%
Disease Exacerbation
9%
SARS Coronavirus
9%
Adverse Drug Reaction
9%
Obesity
9%
Anticarcinogen
9%
Chemoradiation Therapy
9%
Atrial Fibrillation
9%
Coronavirinae
9%
Dacarbazine
9%
Glutathione
8%
Elimination
8%
Comorbidity
8%
Adverse Event
8%
Methionine
8%
Matrilysin
8%
Respiratory Tract
8%
Acetylsalicylic Acid
8%
Acute Leukemia
8%
Ipilimumab
8%
Adenoma
8%
Microparticle
8%
Mouse Model
8%
Hypoxia
7%
Acute Myeloid Leukemia
7%
Effusion
7%
Zoledronic Acid
7%
Keyphrases
Asthma
54%
Women's Health Initiative
37%
Confidence Interval
37%
Postmenopausal Women
25%
Physical Activity
24%
Wheezing
22%
Hazard Ratio
22%
Southwest Oncology Group
21%
Breast Cancer
20%
Body Mass Index
18%
Tumor
17%
Odds Ratio
15%
Sleep Duration
15%
Chemotherapy
15%
Randomized Trial
14%
Obesity
14%
Placebo
13%
Heart Failure with Preserved Ejection Fraction (HFpEF)
13%
Prostate Cancer
13%
Group Studies
12%
Lung Function
12%
Metastatic Breast Cancer
11%
Inhaled Corticosteroids
11%
Nonalcoholic Steatohepatitis
11%
Obstructive Sleep Apnea
11%
Insomnia
11%
Clinical Trials
11%
Colon Cancer
11%
Overall Survival
10%
Childhood Asthma
10%
Non-alcoholic Fatty Liver Disease (NAFLD)
10%
Imexon
10%
Phase II Trial
10%
Risk Factors
10%
Heart Failure
10%
In Cancer
10%
Randomized Controlled Trial
10%
Colorectal Adenoma
9%
United States
9%
Sleep Health
9%
Randomized Clinical Trial
9%
Melanoma
9%
Cisplatin
9%
Human Prostate
8%
Early Breast Cancer
8%
Lower Respiratory Tract Infection
8%
Lung Cancer
8%
Colorectal Cancer
8%
Lymphocytes
8%
Sleep Disturbance
8%
Allergy
7%
Older Adults
7%
Cardiovascular Disease
7%
Hispanic
7%
Phase II Study
7%
Vitamin D
7%
Disease-free Survival
7%
Dietary Intervention
7%
Clinical Outcomes
7%
Spironolactone
7%
COVID-19
7%
Cancer Survivors
6%
Dietary Modification
6%
Denosumab
6%
Tucson
6%
Preschool children
6%
Race-ethnicity
6%
Suicidal Ideation
6%
Lipopolysaccharide
6%
Integrin
6%
AIDS/HIV
6%
Mouse Model
6%
Cancer Patients
6%
Early childhood
6%
High Risk
6%
Dietary Intake
6%
Low-fat Diet
6%
Fluticasone Propionate
6%
Matrilysin
6%
Tumor Necrosis Factor-α
6%
Selenium
6%
Progression-free Survival
6%
Patients with Heart Failure
6%
Gene Expression
6%
Chemoimmunotherapy
6%
Forced Expiratory Volume in 1 Second (FEV1)
6%
Prostate Carcinoma
5%
Atopy
5%
Toll-like
5%
Bone Metastasis
5%
TOPCAT Trial
5%
Remission
5%
Polymorphism
5%
Natural History
5%
African American
5%
Myocardial Infarction
5%
Adult Life
5%
Quality of Life
5%
Soluble CD14 (sCD14)
5%
Tumor Cells
5%